130 related articles for article (PubMed ID: 16621147)
1. Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection.
Cirioni O; Giacometti A; Ghiselli R; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Licci A; Skerlavaj B; Zanetti M; Saba V; Scalise G
Peptides; 2006 Sep; 27(9):2104-10. PubMed ID: 16621147
[TBL] [Abstract][Full Text] [Related]
2. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection.
Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Silvestri C; Orlando F; Kamysz W; Licci A; Nadolski P; Della Vittoria A; Łukasiak J; Scalise G; Saba V
JPEN J Parenter Enteral Nutr; 2007; 31(6):463-8. PubMed ID: 17947600
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Silvestri C; Licci A; De Fusco M; Provinciali M; Saba V; Scalise G
Antimicrob Agents Chemother; 2005 Oct; 49(10):4042-5. PubMed ID: 16189078
[TBL] [Abstract][Full Text] [Related]
5. Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection.
Giacometti A; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Renzone G; Testa I; Mocchegiani F; Della Vittoria A; Saba V; Scaloni A; Scalise G
J Biomed Mater Res A; 2007 Apr; 81(1):233-9. PubMed ID: 17120214
[TBL] [Abstract][Full Text] [Related]
6. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
[TBL] [Abstract][Full Text] [Related]
7. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
[TBL] [Abstract][Full Text] [Related]
8. BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.
Orlando F; Ghiselli R; Cirioni O; Minardi D; Tomasinsig L; Mocchegiani F; Silvestri C; Skerlavaj B; Riva A; Muzzonigro G; Saba V; Scalise G; Zanetti M; Giacometti A
Peptides; 2008 Jul; 29(7):1118-23. PubMed ID: 18430491
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.
Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B
Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597
[TBL] [Abstract][Full Text] [Related]
10. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.
Curtin J; Cormican M; Fleming G; Keelehan J; Colleran E
Antimicrob Agents Chemother; 2003 Oct; 47(10):3145-8. PubMed ID: 14506022
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide.
Yang S; Lee CW; Kim HJ; Jung HH; Kim JI; Shin SY; Shin SH
Peptides; 2019 Aug; 118():170106. PubMed ID: 31226350
[TBL] [Abstract][Full Text] [Related]
12. Testing cathelicidin susceptibility of bacterial mastitis isolates: Technical challenges and data output for clinical isolates.
Langer MN; Blodkamp S; Bayerbach M; Feßler AT; de Buhr N; Gutsmann T; Kreienbrock L; Schwarz S; von Köckritz-Blickwede M
Vet Microbiol; 2017 Oct; 210():107-115. PubMed ID: 29103679
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic central line-associated bloodstream infections in children implanted with long term indwelling central venous catheters in a teaching hospital, Sri Lanka.
Jayaweera JAAS; Sivakumar D
BMC Infect Dis; 2020 Jun; 20(1):457. PubMed ID: 32600427
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients.
Pompilio A; Scocchi M; Pomponio S; Guida F; Di Primio A; Fiscarelli E; Gennaro R; Di Bonaventura G
Peptides; 2011 Sep; 32(9):1807-14. PubMed ID: 21849157
[TBL] [Abstract][Full Text] [Related]
15. Model of Staphylococcus aureus central venous catheter-associated infection in rats.
Ulphani JS; Rupp ME
Lab Anim Sci; 1999 Jun; 49(3):283-7. PubMed ID: 10403443
[TBL] [Abstract][Full Text] [Related]
16. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Garcia R; Raad I
Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):933-6. PubMed ID: 9031876
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.
van de Wetering MD; van Woensel JB; Lawrie TA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD003295. PubMed ID: 24277633
[TBL] [Abstract][Full Text] [Related]
18. Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique.
Capdevila JA; Gavaldà J; Fortea J; López P; Martin MT; Gomis X; Pahissa A
Clin Microbiol Infect; 2001 Apr; 7(4):206-12. PubMed ID: 11422243
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Cathelicidin-Mimetic Antimicrobial Peptoids against Staphylococcus aureus.
Benjamin AB; Moule MG; Didwania MK; Hardy J; Saenkham-Huntsinger P; Sule P; Nielsen JE; Lin JS; Contag CH; Barron AE; Cirillo JD
Microbiol Spectr; 2022 Jun; 10(3):e0053422. PubMed ID: 35467395
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections.
Van Praagh AD; Li T; Zhang S; Arya A; Chen L; Zhang XX; Bertolami S; Mortin LI
Antimicrob Agents Chemother; 2011 Sep; 55(9):4081-9. PubMed ID: 21709082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
